TargetBeta
VEGFA
vascular endothelial growth factor A · also VEGF-A, VPF, VEGF · VEGF family
23 programs in company-led studies act on VEGFA, from 21 companies: 8 in phase 3, 4 approved with new studies. Each with where its target was read from.
Programs
Furthest phase first. A target read by rule is marked rule (17 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.
Conditions their studies are in
- Carcinoma, Non-Small-Cell Lung, 9 programs
- Colorectal Neoplasms, 6 programs
- Macular Degeneration, 4 programs
- Neoplasms, 4 programs
- Ovarian Neoplasms, 4 programs
- Breast Neoplasms, 3 programs
- Carcinoma, Hepatocellular, 3 programs
- Macular Edema, 3 programs
- Small Cell Lung Carcinoma, 3 programs
- Choroidal Neovascularization, 2 programs
Primary completions ahead
Each program’s next study to reach its primary completion, by the sponsor’s estimate.
- Nov 30, 2026Bevacizumab · Hoffmann-La Roche · phase 4 · NCT03148418
- Dec 2026ivonescimab · Akeso · phase 3 · NCT05689853
- Dec 2026Anti-PD-1/Anti-VEGF Bispecific Antibody MK-2010 · Merck · phase 2 · NCT06650566
- Dec 30, 2026Anti-PD-1/Anti-CTLA-4/Anti-VEGF Trispecific Antibody HC010 · HC Biopharma · phase 2 · NCT07169552
- Jan 2027CS2009 · CStone Pharmaceuticals · phase 2 · NCT06741644
- Jan 1, 2027pumitamig · BioNTech · phase 3 · NCT05879055
- Jan 26, 2027faricimab · Hoffmann-La Roche · phase 4 · NCT05224102
- Feb 4, 2027Ranibizumab · Novartis · phase 4 · NCT04657289
What this can’t show
- Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
- A target read by rule can be wrong; each program’s page quotes the words it was read from.
- “Acts on” does not say how: an agonist and an antagonist of the same receptor are listed together (avexitide blocks the GLP-1 receptor that semaglutide activates).
- Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.